Galderma (SIX: GALD), the pure-play dermatology category leader, today announced the first patient enrollment for its phase ...

Giredestrant is the only oral SERD to show superior invasive disease-free survival in the adjuvant setting, marking the first significant endocrine therapy advance in over 20 years1-3 Transformational ...

Rezolute (RZLT) is poised for growth with key Phase 3 trial results ahead. Ersodetug targets both congenital and ...

Philadelphia, PA, USA, December 9, 2025, First Patient Enrolled in GOG-3133/ FRAmework-01 Phase 3 Study Evaluating Sofetabart ...

Experts at SICP 2025 outline how molecular mechanisms and bedside assessments can guide personalised treatment for ...

Based on the response data, coupled with the supportive IFN- <GAMMA> biomarker data, Pliant plans to accelerate the development of PLN-101095 with the initiation of a Phase 1b indication expansion ...

Ischemic stroke is a complex cerebrovascular disorder characterized by highly unpredictable outcomes influenced by patient-specific variables, including age, stroke severity, and preventable ...

Abstract: This study investigates the role of noradrenergic signaling in the antinociceptive effects of intraspinal microstimulation intended to restore movement after spinal cord injury. Two rat ...

A long‑running HyperX favourite evolves with huge battery life, clean sound, and seamless dual wireless—though the pricey base station isn't for everyone. PC Gamer's got your back Our experienced team ...

Sodium-glucose cotransporter-2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP1RA) not only lower blood sugar but also reduce cardiovascular events and improve outcomes in ...

Ashes of Creation is back for testing. Those who have access to the alpha keys can jump into the game and test out plenty of new and updated features. Phase 3 of the Alpha 2 testing window has got a ...